Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05480722 · ClinicalTrials.gov registry record · NA
Central Sodium Sensing: Implications for Blood Pressure Regulation
A NA study of Salt-Sensitivity of Blood Pressure, sponsored by University of Delaware.
- Completed
- Registry status
- NA
- Development phase
- 29
- Enrollment target
- 1
- Study location
NCT05480722 is a NA study of Salt-Sensitivity of Blood Pressure that has completed, run by University of Delaware. The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05480722, a NA study of Salt-Sensitivity of Blood Pressure, has completed, sponsored by University of Delaware.
- COMPLETED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
The ability of the brain to sense changing sodium levels in the blood is critical in mediating the neurohumoral responses to hypernatremia, however, the mechanisms underlying sodium sensing in humans is poorly understood. The purpose of this study is to identify key sodium-sensing regions of the human brain in older adults and determine if the Na-K-2Cl co-transporter mediates the neurohumoral response to acute hypernatremia. Completion of this project will increase our understanding of blood pressure regulation, which has major public health implications.
Conditions Studied
Interventions
- OTHER Hypertonic Saline with furosemide
- OTHER Hypertonic Saline without furosemide
Study Locations (1)
Delaware
- William B Farquhar - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2022-06-01 |
| Est. Completion | 2025-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05480722
The ClinicalTrials.gov registry entry for NCT05480722 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Delaware, which has 106 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Salt-Sensitivity of Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Hypertonic Saline with furosemide is the first listed.
NCT05480722 reports 1 study location spanning 1 distinct geographic area - top geographies include Delaware.
Frequently Asked Questions
What is clinical trial NCT05480722 about?
NCT05480722 is a clinical study titled "Central Sodium Sensing: Implications for Blood Pressure Regulation". The ability of the brain to sense changing sodium levels in the blood is critical in mediating the neurohumoral responses to hypernatremia, however, the mechanisms underlying sodium sensing in humans is poorly understood. The purpose of this study is to identify key sodium-sensing regions of the hum...
What is the current status of trial NCT05480722?
This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2022-06-01. Estimated completion is 2025-01-31.
What conditions does trial NCT05480722 study?
This clinical trial studies the following conditions: Salt-Sensitivity of Blood Pressure.
What interventions are being tested in trial NCT05480722?
The interventions under investigation include: Hypertonic Saline with furosemide (OTHER), Hypertonic Saline without furosemide (OTHER).
Who is sponsoring clinical trial NCT05480722?
This trial is sponsored by University of Delaware, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05480722 being conducted?
This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Salt-Sensitivity of Blood Pressure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.